Skin cancer diagnoses in the UK during the COVID-19 pandemic

  • Andrew TW & al.
  • Clin Exp Dermatol
  • 5 Aug 2020

  • curated by Pavankumar Kamat
  • UK Medical News
Access to the full content of this site is available only to registered healthcare professionals. Access to the full content of this site is available only to registered healthcare professionals.

There has been a decrease in overall skin cancer diagnoses in the UK during the first three months of the COVID-19 pandemic, a new study suggests.

Researchers analysed data from the Northern Cancer Network for the period between 23 March 2020 and 23 June 2020, corresponding with the COVID-19 lockdown in the UK. Percentage change in skin cancer diagnoses and skin cancer waiting times were compared for the COVID-19 period and the same period last year.

There was a 68.61 per cent reduction in the diagnoses of skin cancer when the COVID-19 period was compared with the corresponding period last year (P<.0028 surprisingly a reduction in skin cancer waiting times was also witnessed between the two periods median days to p>

According to the authors, reduced waiting times could be a result of prioritisation of cancer referrals and an overall reduction in skin cancer referrals from primary care. The reluctance of the patients to seek medical attention during the pandemic may have contributed to the decreased referral rates. They also believe that greater use of telemedicine may have enabled appropriate triage of lesions which would otherwise need in-person assessment by a specialist.

Writing in the journal Clinical and Experimental Dermatology, the authors said: "As the pandemic endures, it is particularly crucial for both doctors and patients to be aware of the decreasing presentation of skin cancers and shortened waiting times to facilitate thoughtful and transparent decision making."